*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Icotinib is a third-generation <strong>EGFR tyrosine kinase inhibitor</strong> synthesized via multi-step organic coupling. Its molecular formula is C<sub>27</sub>H<sub>29</sub>N<sub>5</sub>O<sub>4</sub>, with CAS No. 100682-68-4.</p>
<h3>Application</h3>
<ul>
<li><strong>Oncology Manufacturing:</strong> Active pharmaceutical ingredient (API) production for non-small cell lung cancer (NSCLC).</li>
<li><strong>Research & Development:</strong> Preclinical studies on EGFR-mutant tumor mechanisms.</li>
<li><strong>Contract Manufacturing:</strong> Bulk supply for generic drug formulation companies.</li>
</ul>
<h3>Precautions</h3>
<p>Store in sealed containers at 2–8°C protected from light. Strictly comply with GMP guidelines; avoid inhalation of dust and direct skin contact during handling.</p>